Humoral and cellular immunities elicited by DNA vaccines: Application to the human immunodeficiency virus and influenza

Advanced Drug Delivery Reviews

Volumn 21, Issue 1, 1996, Pages 19-31

  Shiver, John W ^a   Ulmer, Jeffrey B ^a   Donnelly, John J ^a   Liu, Margaret A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CTL; DNA vaccines; gp120; Helper T cells; HIV; Influenza; Rev

Indexed keywords

ANTIBODIES; ANTIGENS; CELLS; DISEASES; DNA; IMMUNOLOGY; NUCLEIC ACIDS; PHYSIOLOGICAL MODELS; VIRUSES;

CELLULAR IMMUNITIES; DNA VACCINES; FERRETS; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL COMMUNITIES; INFLUENZA; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; PLASMID DNA;

VACCINES;

GLYCOPROTEIN GP 120; HEMAGGLUTININ; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOPROTEIN; PLASMID DNA; REV PROTEIN; VACCINE;

ANIMAL MODEL; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; FERRET; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VACCINATION;

EID: 0030581320     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(96)00019-1     Document Type: Review

References (57)

1. [1] Donnelly, J.J., Ulmer, J.B. and Liu, M.A. (1994). Immunization with DNA. J. Immunol. Meth. 176, 145.
2. [2] Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Dwarki, V.J., Gromkowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., Hawe, L.A., Leander, K.R., Martinez, D., Perry, H.C., Shiver, J.W., Montgomery, D.L. and Liu, M.A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745.
3. [3] Ulmer, J.B., Deck, R.R., DeWitt, C.M., Friedman, A., Donnelly, J.J. and Liu, M.A. (1994). Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12, 1541.
4. [4] Schirmbeck, R., Melber, K., Kuhrober, A., Janowicz, Z.A. and Reimann, J. (1994). Immunization with soluble hepatitis-B virus surface protein elicits murine H-2 class I-restricted CD8 + cytotoxic T-lymphocyte responses in vivo. J. Immunol. 152, 1110.
5. [5] Donnelly, J.J., Friedman, A., Martinez, D., Montgomery, D.L., Shiver, J.W., Motzel, S.L., Ulmer, J.B. and Liu, M.A. (1995). Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus. Nature Medicine 1, 583.
6. [6] Montgomery, D.L., Shiver, J.W., Leander, K.R., Perry, H.C., Friedman, A. Martinez, D., Ulmer, J.B., Donnelly, J.J. and Liu, M.A. (1993). Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors. DNA and Cell Biol. 12, 777.
7. [7] Robinson, H.L., Hunt, L.A. and Webster, R.G. (1993). Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 9, 957.
8. [8] Webster, R.G., Fynan, E.F., Santoro, J.C. and Robinson, H. (1994). Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12, 1495.
9. [9] Wang, B., Ugen, K.E., Srikantan, V., Sato, A.I., Boyer, J., Williams, W.V. and Weiner, D.B. (1993). Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 90, 4156.
10. [10] Coney, L., Wang, B., Ugen, K.E., Boyer, J., McCallus, D., Srikantan, V., Agadjanyan, M., Pachuk, C.J., Herold, K., Merva, M., Gilbert, L., Deng, K., Moelling, K., Newman, M., Williams, W.V. and Weiner, D.B. (1994). Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 12, 1545.
11. [11] Wang, B., Boyer, J., Srikantan, V., Ugen, K., Gilbert, L., Phan, C., Dang, K., Merva, M., Agadjanyan, M.G., Newman, M., Carrano, R., McCallus, D., Coney, L., Williams, W.V. and Weiner, D.B. (1995). Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation. Virology 211, 102.
12. [12] Davis, H.L., Michel, M-L. and Whalen, R.G. (1993). DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2, 1847.
13. [13] Davis, H.L., Whalen, R.G. and Demeneix, B.A. (1993). Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151.
14. [14] Cox, G.J.M., Zamb, T.J. and Babiuk, L.A. (1993). Bovine herpesvirus 1: Immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67, 5664.
15. [15] Manickan, E., Rouse, R.J.D., Yu, Z., Wire, W.S. and Rouse, B.T. (1995). Genetic immunization against herpes simplex virus: Protection is mediated by CD4 + T lymphocytes. J. Immunol. 155, 259.
16. [16] Xiang, Z.G., Spitalnik, S.L., Cheng, J., Erikson, J., Wojczyk, B. and Ertl, H.C. (1995). Immune responses to nucleic acid vaccines to rabies virus. Virology, 209, 569.
17. [17] Xiang, Z.G., Spitalnik, S.L., Tran, M., Wunner, W.H., Cheng, J. and Ertl, H.C. (1994). Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology, 199, 132.
18. [18] Donnelly, J.J., Martinez, D., Jansen, K., Montgomery, D.L. and Liu, M.A. (1995). Protection against papilloma virus with a polynucleotide vaccine. J. Clin. Invest. (in press).
19. [19] Huygen, K., Ulmer, J.B., Denis, O., Montgomery, D.L., Yawman, A., Drowart, A., Lozes, E.,Vandenbussche, P., van Vooren, J,. Liu, M.A. and Content, J. (1995). submitted for publication.
20. [20] Lagging, L.M., Meyer, K., Hoft, D., Houghton, M., Belshe, R.B. and Ray, R. (1995). Immune responses to plasraid DNA encoding hepatitis C virus core protein. J. Virol. 69, 5859.
21. [21] Pedroz Martins, L., Lau, L.L., Asano, M.S. and Ahmed, R. (1995). DNA vaccination against persistent viral infection. J. Virol. 69, 2574.
22. [22] Yokohama, M., Zhang, J. and Whitton, J.L. (1995). DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69, 2684.
23. [23] Sedegah, M., Hedstrom, R., Hobart, P. and Hoffman, S.L. (1994). Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA. 91, 9866.
24. [24] Hoffman, S.L., Sedegah, M. and Hedstrom, R.C. (1994). Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 12, 1529.
25. [25] Xu, D. and Liew, F.Y. (1995). Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein. gp63, of L. major. Immunology, 84, 173.
26. [26] Conry, R.M., LoBuglio, L.F., Kantor, J., Schlom, J., Loechel, F., Moore, S.E., Sumerel, L.A., Barlow, D.L., Abrams, S, and Curiel, D.T. (1994). Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54, 1164.
27. [27] Tang, D-C., DeVit, M. and Johnston, S.A. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature, 356, 152.
28. [28] Eisenbraun, M.D., Fuller, D.H. and Haynes, J.R. (1993). Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA and Cell Biol. 12, 791.
29. [29] Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. (1993). DNA vaccines: Protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 90, 11478.
30. [30] Haynes, J.R., Eisenbraun, M.D., Fuller, D.H., Fynan, E.F. and Robinson, H.L. (1994). Gene gun-mediated DNA immunization elicits humoral, cytotoxic and protective immune responses. Vaccines 94, Cold Spring Harbor Laboratory Press, 65.
31. [31] Fuller, D.H. and Haynes, J.R. (1994). A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retrovir. 10, 1433.
32. [32] Zarozinski, C.C., Fynan, E.F., Selin, L.K., Robinson, H.L. and Welsh, R.M. (1995). Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding and internal virion protein. J. Immunol. 154, 4010,
33. [33] Vahlsing, H.L., Yankauckas, M.A., Sawdey, M., Gromkowski, S.H. and Manthorpe, M. (1994). Immunization with plasmid DNA using a pneumatic gun. J. Immunol. Meth. 175, 11.
34. [34] Gorman, C.M., Merlino, G.T., Willingham, M.C., Pastan, I. and Howard, B.H. (1982). The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci, U.S.A. 79, 6777.
35. [35] Boshart, M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B. and Schaffner, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521.
36. [36] Moreau, P., Hen, R., Wasylyk, B., Everett, R., Gaub, M.P. and Chambon, P. (1981). The SV40 72 base pair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucl. Acids Res. 9, 6047.
37. [37] Pfarr, D.S., Rieser, L.A., Woychik, R.P., Rottman, F.M., Rosenberg, M. and Reff, M.E. (1986). Differential effects of polyadenylation regions on gene expression in mammalian cells. DNA 5, 115.
38. [38] Chapman, B.S., Thayer, R.M., Vincent, K.A. and Haigwood, N.L. (1991). Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19, 3979.
39. [39] Liu, M.A., Davies, M-E., Yasutomi, Y., Perry, H.C., Letvin, N.L. and Shiver, J.W. (1994). Immune responses to HIV generated by DNA vaccines. In: M. Girard and B. Dodet, (Eds.), Retroviruses of Human AIDS and Related Animal Diseases. Fondation Marcel Mérieux, pp. 197.
40. [40] Liu, M.A., Yasutomi, Y, Davies, M-E., Perry, H.C., Freed, D.C., Letvin, N.L. and Shiver, J.W. (1995). Vaccination of mice and nonhuman primates using HIV-gene-containing DNA. Antibiotics and Chemotherapy 48 (in press).
41. [41] Shiver, J.W., Perry, H.C., Davies, M-E. and Liu, M.A. (1995). In: Chanock, R.M., Brown, F., Ginsberg, H.S. and Norrby, Erling, (Eds), Immune responses to HIV gp120 elicited by DNA vaccination. Vaccines 95, Cold Spring Harbor Laboratory Press, 95.
42. [42] Shiver, J.W., Perry, H.C., Davies, M-E., Freed, D.L. and Liu, M.A. (1995). Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination. Ann. NY Acad. Sci. 772, 198.
43. [43] Takahashi, H., Cohen, J., Hosmalin, A., Cease, K.B., Houghten, R., Cornette, J.L., DeLisi, C., Moss, B., Germain, R.N. and Berzofsky, J.A. (1988). An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 85, 3105.
44. [44] Broder, C.C., Earl, P.L., Long, D., Abedon, S.T., Moss, B. and Doms, R.W. (1994). Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: Oligomer-specific and sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 91, 11699.
45. [45] Koup, RA., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing and D.D. Ho (1994). Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650.
46. [46] Romagnani, S. (1991). Type-1 T helper and type-2 T helper cells: Functions, regulation and role in protection and disease. Int. J. CHn. Lab. Res. 21, 152.
47. H2 cells. J. Clin. Immunol. 15, 121.
48. [48] Street, N.E. and Mosmann, T.R. (1991). Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5, 171.
49. [49] Clerici, M. and Shearer, G.M. (1993). A Th1>Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today, 14, 107.
50. [50] Heinzel, F.P. (1995). Th1 and Th2 cells in the cure and pathogenesis of infectious diseases. Curr. Opin. Infect. Dis. 8, 151.
51. [51] Wolff, J.A., Malone, R.W., Williams, P., Wang, C., Acsadi, G., Jani, A. and Felgner, P.L. (1990). Direct transfer into mouse muscle in vivo. Science 247, 1465.
52. [52] Wolff, J.A., Williams, P., Acsadi, G., Jani, A. and Chong, W. (1991). Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 11, 474.
53. [53] Benoit, P.W. and Belt, W.D. (1970). Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic bupivicaine (marcaine). J. Anat. 107, 547.
54. [54] Danko, I., Fritz, J.D., Jiao, S., Hogan, K., Latendresse, J.S. and J.A. Wolff (1994). Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1, 114.
55. [55] Vitadello, M., Schiaffino, M.V., Picard, A., Scarpa, M. and Schiaffino, S. (1994). Gene transfer in regenerating muscle. Hum. Gene Ther. 5, 11.
56. [56] Wells, D.J. (1993). Improved gene transfer by direct plasmid injection associated wtih regeneration in mouse skeletal muscle. FEBS Lett. 332, 179.
57. [57] Raz, E., Carson, D.A., Parker, S.E., Parr, T.B., Abai, A.M., Aichinger, G., Gromkowski, S.H., Singh, M., Lew, D., Yaankauckas, M.A., Baird, S.M. and Rhodes, G.H. (1994). Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. U.S.A. 91, 9519.